For those reasons, the Court held that Apoteket's system of selecting medicinal preparations is liable to place at a disadvantage medicinal preparations from other Member States and that that sales monopoly is not therefore arranged in such a way as to rule out any discrimination against such medicinal preparations.
Nendel põhjustel leiab Euroopa Kohus, et Apoteket’i ravimite valiku süsteem võib teistest liikmesriikidest pärinevad ravimid panna ebasoodsasse olukorda ning et seda müügimonopoli ei ole seega kohandatud nii, et oleks välistatud selliste ravimite diskrimineerimine.